Latest Articles

Publication Date
UK: Trans-Identified Male Appointed To Top Endometriosis Charity Role - reduxx.info

UK: Trans-Identified Male Appointed To Top Endometriosis Charity Role reduxx.info

Published: March 24, 2026, 9:11 p.m.
Once-daily pill for endometriosis approved for use on the NHS - MSN

Once-daily pill for endometriosis approved for use on the NHS MSN

Published: March 24, 2026, 4:01 p.m.
Trans row: Outrage after transgender woman appointed as endometriosis charity representative - GB News

Trans row: Outrage after transgender woman appointed as endometriosis charity representative GB News

Published: March 24, 2026, 7:13 a.m.
Endometrial epithelial cells with high ALDH activity control uterine development and regeneration.

Adult stem cells are thought to drive the regenerative potential of the endometrium and contribute to the pathogenesis of endometriosis, however, their identity and defining features remain to be characterized. …

Published: March 24, 2026, midnight
FDA clears ENDO-205 Investigational New Drug application for endometriosis - Contemporary OB/GYN

FDA clears ENDO-205 Investigational New Drug application for endometriosis Contemporary OB/GYN

Published: March 23, 2026, 7:30 p.m.
Fury as trans woman is appointed to represent an endometriosis charity - who say condition 'affects people of all genders' - Daily Mail

Fury as trans woman is appointed to represent an endometriosis charity - who say condition 'affects people of all genders' Daily Mail

Published: March 23, 2026, 4:17 p.m.
Fury as trans woman is appointed to represent an endometriosis charity - who say condition 'affects people of all genders' - dailymail.co.uk

Fury as trans woman is appointed to represent an endometriosis charity - who say condition 'affects people of all genders' dailymail.co.uk

Published: March 23, 2026, 4:17 p.m.
EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis - BioSpace

EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis BioSpace

Published: March 23, 2026, 12:47 p.m.
EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis - PR Newswire

EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis PR Newswire

Published: March 23, 2026, 11:30 a.m.
Outrage after transgender woman appointed as endometriosis charity representative - MSN

Outrage after transgender woman appointed as endometriosis charity representative MSN

Published: March 23, 2026, 11:08 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!